Biopharmaceutical Drug Discovery and Development

Biopharmaceutical Drug Design and Development, investigates the dozens of new biopharmaceutical drugs that have become available since that time. Among the drugs discussed are ones in the categories of monoclonal antibodies for in-vivo use, cytokines, growth factors, enzymes, immunomodulators, thrombolytics, and immonotherapies including vaccines. Which also covers the new and emerging technologies, such as bioinformatics, DNA microarrays, transgenics, therapeutic gene delivery, stem cells, nucleic acid-based therapeutics, and macromolecular drug delivery. Participants also present pharmacogenetics in the clinic and changes in biologic drug approval at the FDA.